Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Remdesivir bulk supplier for pharma manufacturers

Remdesivir Suppliers & Bulk Manufacturers

Available Forms: Lyophilized powder for IV & Injection

Available Strengths: Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)

Reference Brands: Veklury® (EU & US)

Category: Anti Covid Medicines

Remdesivir 100 mg lyophilised powder and 100 mg/20 mL concentrate for intravenous infusion, an antiviral for COVID-19. For hospitals, tender suppliers and licensed importers in markets where the licence and registration position allows supply.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Remdesivir? List it or send an offer →

Product Description:

Remdesivir is a nucleotide analogue prodrug. Inside cells it becomes an active triphosphate that the SARS-CoV-2 RNA polymerase takes up in place of a natural building block, which halts viral RNA synthesis. Poor oral bioavailability means it is given only intravenously. This page lists a 100 mg vial of lyophilised powder, reconstituted with sterile water and diluted in sodium chloride 0.9%, and a 100 mg/20 mL (5 mg/mL) concentrate that only needs dilution. The powder is more common because it needs no refrigeration.

Remdesivir is approved for COVID-19 in hospitalised adults and children, particularly those with pneumonia needing oxygen, and as a three-day course for high-risk patients not needing oxygen. Adults usually receive 200 mg on day one, then 100 mg once daily, each infused over 30 to 120 minutes. Liver function and prothrombin time are checked before and during treatment. Infusion and hypersensitivity reactions can occur, so patients are observed. Chloroquine and hydroxychloroquine are avoided because they can reduce its antiviral activity.

Sourcing notes. Remdesivir remains under patent in many countries, and some generic versions may be sold only in territories covered by voluntary licences, so confirm the licence and patent position for your market first. It is a prescription-only hospital medicine needing registration, emergency authorisation, or a tender or named-patient route. Store the powder below 30 °C and the concentrate at 2-8 °C, as labelled. Ask for the CTD or ACTD dossier, Zone IVb stability data, a certificate of analysis for each batch, GMP certificate and CoPP.

Remdesivir — third party manufacturing & bulk supply

Remdesivir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Remdesivir is supplied as Lyophilized powder for IV & Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Remdesivir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Remdesivir →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Several Indian manufacturers make remdesivir under Gilead's 2020 licences, though not all of them still produce it regularly. We match your enquiry with licensed makers that can supply your market and confirm current availability and documents.

No. The Gilead licences allow sale in a defined list of 127 countries, mostly low- and middle-income. For a market outside that list, patent and registration status must be checked first.

100 mg per vial, mainly as a lyophilised powder for reconstitution and dilution. A 100 mg/20 mL (5 mg/mL) solution was also approved in the US but is no longer in the current US label.

Under the US label, the lyophilised powder is stored below 30 °C; the older solution concentrate needed 2 to 8 °C. Storage statements differ between countries and products, so follow the labelling of the product you buy.

Related Products

Favipiravir Tablet

Strength:
200 mg, 400 mg, 600 mg

Form: Tablet

Reference Brands: Avigan

View Details
Molnupiravir

Strength:
200 mg

Form: Oral capsule

Reference Brands: Lagevrio®(Us & EU)

View Details
Tocilizumab

Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)

Form: IV injection, SQ Injection

Reference Brands: Actemra®(US); RoActemra®(EU)

View Details
Nirmatrelvir / Ritonavir Tablet

Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)

Form: Tablet

Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)

View Details
Baricitinib

Strength:
2 mg, 4 mg

Form: Tablet

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us